MicroBplex Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
MicroBplex General Information
Description
Operator of a biotechnology company intended to develop novel technology to detect nascent antibody-secreting cells (ASCs). The company focuses on early detection and assessment of therapeutic effectiveness and distinguishing new infections from prior infections, enabling healthcare professionals to record diagnostic information essential for effective early therapeutic intervention.
Contact Information
Website
www.microbplex.comCorporate Office
- 1910 Durand Mill Drive
- Atlanta, GA
- United States
Corporate Office
- 1910 Durand Mill Drive
- Atlanta, GA
- United States
MicroBplex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Out of Business | 11-Nov-2025 | Completed | Out of Business | |||
| 8. Later Stage VC | Completed | Generating Revenue | ||||
| 7. Grant | 01-Jan-2018 | Completed | Generating Revenue | |||
| 6. Grant | 08-Sep-2017 | Completed | Generating Revenue | |||
| 5. Grant | 30-Jun-2016 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2015 | Completed | Generating Revenue | |||
| 3. Grant | 28-May-2014 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2014 | $150K | Completed | Generating Revenue | ||
| 1. Grant | 20-Jul-2012 | $25K | Completed | Generating Revenue |
MicroBplex Patents
MicroBplex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210072257-A1 | Methods of diagnosing lyme disease | Inactive | 09-Sep-2019 | ||
| US-10247729-B2 | Media elaborated with newly synthesized antibodies (mensa) and uses thereof | Active | 05-May-2014 | ||
| US-20160077094-A1 | Media elaborated with newly synthesized antibodies (mensa) and uses thereof | Active | 05-May-2014 | ||
| US-20200072836-A1 | Media elaborated with newly synthesized antibodies (mensa) and uses thereof | Inactive | 05-May-2014 | ||
| EP-2942627-A1 | Media elaborated with newly synthesized antibodies (mensa) from recently proliferated antibody secreting cells (asc) and uses thereof | Inactive | 05-May-2014 | G01N33/56972 |
MicroBplex FAQs
-
When was MicroBplex founded?
MicroBplex was founded in 2011.
-
Where is MicroBplex headquartered?
MicroBplex is headquartered in Atlanta, GA.
-
What industry is MicroBplex in?
MicroBplex’s primary industry is Other Devices and Supplies.
-
Is MicroBplex a private or public company?
MicroBplex is a Private company.
-
What is MicroBplex’s current revenue?
The current revenue for MicroBplex is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process